IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Life Science Advisors, LLC

Q1 2026 Holdings

Filed 2026-05-14 | 6 holdings | $790.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kymera Therapeutics, Inc.(KYMR)Common Stock501575104$381.3M4,578,00848.3%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$165.5M9,130,46521.0%
Sionna Therapeutics, Inc.(SION)Common Stock829401108$120.1M2,995,60215.2%
Disc Medicine, Inc.(IRON)Common Stock254604101$96.8M1,513,87512.3%
Q32 Bio, Inc.(QTTB)Common Stock746964105$13.4M2,092,1061.7%
Korro Bio, Inc.(KRRO)Common Stock500946108$12.9M1,137,1491.6%